Tag: Checkpoint Inhibitor Drug
Can Immunotherapy Extend Cancer Patient Survival?
A group of researchers from the Johns Hopkins Kimmel Cancer Center reported a successful clinical trial of using the immunotherapy drug nivolumab...
Melanoma Patients can Now Receive FDA-Approved Immunotherapy Drug
The U.S. Food and Drug Administration (FDA) has now approved the checkpoint inhibitor drug Keytruda to treat stage-3 melanoma after patients have undergone surgery....
